Clinical trial
Study of Oxycyte in Severe Closed Head Injury
NCT00174980 · Tenax Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00174980 |
|---|---|
| Title | Study of Oxycyte in Severe Closed Head Injury |
| Official title | An Open Label, Proof of Concept Study, to Evaluate the Safety and Biological Effects of Oxycyte™ Perfluorocarbon in Patients With A Severe Head Injury Requiring Intracranial Pressure Monitoring-OX-CL-II-002 |
| Lead sponsor | Tenax Therapeutics, Inc., Industry |
| Collaborators | Virginia Commonwealth University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Traumatic Brain Injury |
| Intervention type | Drug |
| Interventions | perfluorocarbon emulsion (Oxycyte) infusion |
| Enrollment | 9 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 10, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: